Friday, May 24, 2013

Hatch Emphasizes Opposition To Price Controls Following Remarks On Drug Rebates

Senate Finance Ranking Member Orrin Hatch (R-UT) declared his “vehement” opposition to extending Medicaid drug rebates to Medicare Part D on Wednesday (Oct. 12), following remarks the previous day in which he said “it's a very important area” and expects the rebate proposal to come up in deficit reduction talks.

You've followed a link to an article or document on InsideHealthPolicy.com.
There are three ways you can access this content.

Subscriber Login

If you are an InsideHealthPolicy.com subscriber, or you have an active trial subscription, please login here:

Take A Trial Subscription

If you haven't already had a trial subscription to InsideHealthPolicy.com, you can sign up for one right now. Just click on the link below to get started -- you'll get full access for one month, including access to our newsletters, Inside CMS and FDA Week, plus daily news updates by e-mail and much, much more.

Sign up for a trial subscription.

Buy This Article

You can also buy this and other individual InsideHealthPolicy.com articles by going to the InsideHealthPolicy.com NewsStand. Articles are $5 apiece. We'll even give you your first download free.

Here's a direct link to this article on the NewsStand.